Literature DB >> 35381062

Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.

Karri Kaivola1,2, Zalak Shah2, Ruth Chia3, Sonja W Scholz2,4.   

Abstract

The APOE locus is strongly associated with risk for developing Alzheimer's disease and dementia with Lewy bodies. In particular, the role of the APOE ε4 allele as a putative driver of α-synuclein pathology is a topic of intense debate. Here, we performed a comprehensive evaluation in 2466 dementia with Lewy bodies cases versus 2928 neurologically healthy, aged controls. Using an APOE-stratified genome-wide association study approach, we found that GBA is associated with risk for dementia with Lewy bodies in patients without APOE ε4 (P = 6.58 × 10-9, OR = 3.41, 95% CI = 2.25-5.17), but not with dementia with Lewy bodies with APOE ε4 (P = 0.034, OR = 1.87, 95%, 95% CI = 1.05-3.37). We then divided 495 neuropathologically examined dementia with Lewy bodies cases into three groups based on the extent of concomitant Alzheimer's disease co-pathology: pure dementia with Lewy bodies (n = 88), dementia with Lewy bodies with intermediate Alzheimer's disease co-pathology (n = 66) and dementia with Lewy bodies with high Alzheimer's disease co-pathology (n = 341). In each group, we tested the association of the APOE ε4 against the 2928 neurologically healthy controls. Our examination found that APOE ε4 was associated with dementia with Lewy bodies + Alzheimer's disease (P = 1.29 × 10-32, OR = 4.25, 95% CI = 3.35-5.39) and dementia with Lewy bodies + intermediate Alzheimer's disease (P = 0.0011, OR = 2.31, 95% CI = 1.40-3.83), but not with pure dementia with Lewy bodies (P = 0.31, OR = 0.75, 95% CI = 0.43-1.30). In conclusion, although deep clinical data were not available for these samples, our findings do not support the notion that APOE ε4 is an independent driver of α-synuclein pathology in pure dementia with Lewy bodies, but rather implicate GBA as the main risk gene for the pure dementia with Lewy bodies subgroup. Published by Oxford University Press on behalf of the Guarantors of Brain 2022. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  APOE; Alzheimer’s disease; co-pathology; dementia with Lewy bodies

Mesh:

Substances:

Year:  2022        PMID: 35381062      PMCID: PMC9423712          DOI: 10.1093/brain/awab402

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   15.255


  28 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  APOE genotype regulates pathology and disease progression in synucleinopathy.

Authors:  Albert A Davis; Casey E Inman; Zachary M Wargel; Umber Dube; Brittany M Freeberg; Alexander Galluppi; Jessica N Haines; Dhruva D Dhavale; Rebecca Miller; Fahim A Choudhury; Patrick M Sullivan; Carlos Cruchaga; Joel S Perlmutter; Jason D Ulrich; Bruno A Benitez; Paul T Kotzbauer; David M Holtzman
Journal:  Sci Transl Med       Date:  2020-02-05       Impact factor: 17.956

3.  Risk factors for earlier dementia onset in autopsy-confirmed Alzheimer's disease, mixed Alzheimer's with Lewy bodies, and pure Lewy body disease.

Authors:  Jeff Schaffert; Christian LoBue; Charles L White; Kristin Wilmoth; Nyaz Didehbani; Laura Lacritz; Trung Nguyen; Matthew E Peters; Lindy Fields; Chengxi Li; C Munro Cullum
Journal:  Alzheimers Dement       Date:  2020-02-11       Impact factor: 21.566

4.  Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.

Authors:  Rita Guerreiro; Owen A Ross; Celia Kun-Rodrigues; Dena G Hernandez; Tatiana Orme; John D Eicher; Claire E Shepherd; Laura Parkkinen; Lee Darwent; Michael G Heckman; Sonja W Scholz; Juan C Troncoso; Olga Pletnikova; Olaf Ansorge; Jordi Clarimon; Alberto Lleo; Estrella Morenas-Rodriguez; Lorraine Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Janice Holton; Yaroslau Compta; Vivianna Van Deerlin; Geidy E Serrano; Thomas G Beach; Suzanne Lesage; Douglas Galasko; Eliezer Masliah; Isabel Santana; Pau Pastor; Monica Diez-Fairen; Miquel Aguilar; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Tamas Revesz; Andrew Lees; Brad F Boeve; Ronald C Petersen; Tanis J Ferman; Valentina Escott-Price; Neill Graff-Radford; Nigel J Cairns; John C Morris; Stuart Pickering-Brown; David Mann; Glenda M Halliday; John Hardy; John Q Trojanowski; Dennis W Dickson; Andrew Singleton; David J Stone; Jose Bras
Journal:  Lancet Neurol       Date:  2017-12-16       Impact factor: 44.182

5.  Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.

Authors:  Ruth Chia; Marya S Sabir; Sara Bandres-Ciga; Sara Saez-Atienzar; Regina H Reynolds; Emil Gustavsson; Ronald L Walton; Sarah Ahmed; Coralie Viollet; Jinhui Ding; Mary B Makarious; Monica Diez-Fairen; Makayla K Portley; Zalak Shah; Yevgeniya Abramzon; Dena G Hernandez; Cornelis Blauwendraat; David J Stone; John Eicher; Laura Parkkinen; Olaf Ansorge; Lorraine Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Peter St George-Hyslop; Elisabet Londos; Kevin Morgan; Tammaryn Lashley; Thomas T Warner; Zane Jaunmuktane; Douglas Galasko; Isabel Santana; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Nigel J Cairns; John C Morris; Glenda M Halliday; Vivianna M Van Deerlin; John Q Trojanowski; Maurizio Grassano; Andrea Calvo; Gabriele Mora; Antonio Canosa; Gianluca Floris; Ryan C Bohannan; Francesca Brett; Ziv Gan-Or; Joshua T Geiger; Anni Moore; Patrick May; Rejko Krüger; David S Goldstein; Grisel Lopez; Nahid Tayebi; Ellen Sidransky; Lucy Norcliffe-Kaufmann; Jose-Alberto Palma; Horacio Kaufmann; Vikram G Shakkottai; Matthew Perkins; Kathy L Newell; Thomas Gasser; Claudia Schulte; Francesco Landi; Erika Salvi; Daniele Cusi; Eliezer Masliah; Ronald C Kim; Chad A Caraway; Edwin S Monuki; Maura Brunetti; Ted M Dawson; Liana S Rosenthal; Marilyn S Albert; Olga Pletnikova; Juan C Troncoso; Margaret E Flanagan; Qinwen Mao; Eileen H Bigio; Eloy Rodríguez-Rodríguez; Jon Infante; Carmen Lage; Isabel González-Aramburu; Pascual Sanchez-Juan; Bernardino Ghetti; Julia Keith; Sandra E Black; Mario Masellis; Ekaterina Rogaeva; Charles Duyckaerts; Alexis Brice; Suzanne Lesage; Georgia Xiromerisiou; Matthew J Barrett; Bension S Tilley; Steve Gentleman; Giancarlo Logroscino; Geidy E Serrano; Thomas G Beach; Ian G McKeith; Alan J Thomas; Johannes Attems; Christopher M Morris; Laura Palmer; Seth Love; Claire Troakes; Safa Al-Sarraj; Angela K Hodges; Dag Aarsland; Gregory Klein; Scott M Kaiser; Randy Woltjer; Pau Pastor; Lynn M Bekris; James B Leverenz; Lilah M Besser; Amanda Kuzma; Alan E Renton; Alison Goate; David A Bennett; Clemens R Scherzer; Huw R Morris; Raffaele Ferrari; Diego Albani; Stuart Pickering-Brown; Kelley Faber; Walter A Kukull; Estrella Morenas-Rodriguez; Alberto Lleó; Juan Fortea; Daniel Alcolea; Jordi Clarimon; Mike A Nalls; Luigi Ferrucci; Susan M Resnick; Toshiko Tanaka; Tatiana M Foroud; Neill R Graff-Radford; Zbigniew K Wszolek; Tanis Ferman; Bradley F Boeve; John A Hardy; Eric J Topol; Ali Torkamani; Andrew B Singleton; Mina Ryten; Dennis W Dickson; Adriano Chiò; Owen A Ross; J Raphael Gibbs; Clifton L Dalgard; Bryan J Traynor; Sonja W Scholz
Journal:  Nat Genet       Date:  2021-02-15       Impact factor: 38.330

Review 6.  Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.

Authors:  Yu Yamazaki; Na Zhao; Thomas R Caulfield; Chia-Chen Liu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2019-07-31       Impact factor: 44.711

7.  APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.

Authors:  Na Zhao; Olivia N Attrebi; Yingxue Ren; Wenhui Qiao; Berkiye Sonustun; Yuka A Martens; Axel D Meneses; Fuyao Li; Francis Shue; Jiaying Zheng; Alexandra J Van Ingelgom; Mary D Davis; Aishe Kurti; Joshua A Knight; Cynthia Linares; Yixing Chen; Marion Delenclos; Chia-Chen Liu; John D Fryer; Yan W Asmann; Pamela J McLean; Dennis W Dickson; Owen A Ross; Guojun Bu
Journal:  Sci Transl Med       Date:  2020-02-05       Impact factor: 19.319

8.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

9.  BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology.

Authors:  Mariko Taga; Vladislav A Petyuk; Charles White; Galina Marsh; Yiyi Ma; Hans-Ulrich Klein; Sarah M Connor; Alexandra Kroshilina; Christina J Yung; Anthony Khairallah; Marta Olah; Julie Schneider; Kyle Karhohs; Anne E Carpenter; Richard Ransohoff; David A Bennett; Andrea Crotti; Elizabeth M Bradshaw; Philip L De Jager
Journal:  Mol Neurodegener       Date:  2020-07-29       Impact factor: 14.195

10.  GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.

Authors:  Arvid Rongve; Aree Witoelar; Agustín Ruiz; Lavinia Athanasiu; Carla Abdelnour; Jordi Clarimon; Stefanie Heilmann-Heimbach; Isabel Hernández; Sonia Moreno-Grau; Itziar de Rojas; Estrella Morenas-Rodríguez; Tormod Fladby; Sigrid B Sando; Geir Bråthen; Frédéric Blanc; Olivier Bousiges; Afina W Lemstra; Inger van Steenoven; Elisabet Londos; Ina S Almdahl; Lene Pålhaugen; Jon A Eriksen; Srdjan Djurovic; Eystein Stordal; Ingvild Saltvedt; Ingun D Ulstein; Francesco Bettella; Rahul S Desikan; Ane-Victoria Idland; Mathias Toft; Lasse Pihlstrøm; Jon Snaedal; Lluís Tárraga; Mercè Boada; Alberto Lleó; Hreinn Stefánsson; Kári Stefánsson; Alfredo Ramírez; Dag Aarsland; Ole A Andreassen
Journal:  Sci Rep       Date:  2019-05-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.